George Clinical, a leading global clinical research organisation, is pleased to announce the appointment of Tony Proctor, C.P.A., as Chief Financial Officer (CFO). With over 25 years of financial leadership experience, Tony brings a wealth of expertise in driving operational excellence, strategic planning, and transformational growth. “I am honored to join George Clinical and contribute […]
Read More
George Clinical is pleased to confirm the appointment of Mary Gunn as its new Chief Executive Officer. As a global executive, Mary brings to the role extensive experience in high-growth life sciences, financial services, and the education sectors. Mary will also be a director on the Board. Mary Gunn succeeds James Cheong who has served […]
Read MoreRace Oncology Limited recently announce the appointment of George Clinical to support the oncology clinical development of RC220 bisantrene. George Clinical was selected after an extensive and rigorous selection process conducted by the Race Oncology clinical team. In addition to clinical trial expertise, George Clinical, brings access to a supplementary network of key opinion leading […]
Read More40,000 in attendance for 200+ exciting oncology presentations, networking and collaborations. In the lead up to the 2024 ASCO annual meeting, oncology professionals were invited to “Come for the science, stay for the connection and leave with an inspiration that will drive you forward.” Aside from the science, this year’s ASCO theme was also focused […]
Read MoreRace Oncology Limited recently announce the appointment of George Clinical to support the oncology clinical development of RC220 bisantrene. George Clinical was selected after an extensive and rigorous selection process conducted by the Race Oncology clinical team. In addition to clinical trial expertise, George Clinical, brings access to a supplementary network of key opinion leading […]
Read MoreRare diseases affect 350 million globally, but with few available treatments, time is of the essence. If you or a loved one suffered from a rare disease for which there is no treatment or cure, and there was a drug that had shown potential to give you some relief—some hope—you would want to have access […]
Read MoreGeorge Clinical’s global renal team well represented in attendance and presentations. At the opening plenary of Kidney Week 2023, ASN President Michelle A. Josephson acknowledged the contributions that the 12,000 attendees are making in the fight against kidney diseases who are “mounting a daily fight on behalf of your patients—working on matters of existential importance […]
Read MoreWill new treatments decrease potential participants for ongoing and future research? In a world where more efficient and better targeted treatments are being approved at an unprecedented rate, patients are understandably eager to take advantage of the new discoveries, especially when it comes to rare diseases such as Immunoglobulin A nephropathy (IgAN) where safe and […]
Read MoreOmico Will Precisely Match Patients to George Clinical Oncology Trials SYDNEY, July 28, 2023 – George Clinical recognises and applauds its collaborative partner Omico, with whom it is aligned in a common goal to revolutionize oncology clinical trial access for patients and improve the efficiency of study enrollment, on the launch of their landmark program […]
Read More
Patient-centricity is the key to more successful research and adoption of new treatments. ASCO’s 2023 Annual Meeting drew oncology professionals from around the world to learn about new clinical advances in cancer research, gain real-time insights from world-renowned experts and connect with one of the largest, most diverse audiences in global oncology. Peer-to-peer interaction is the […]
Read More
